Pharmaceutical Science Update

November 22, 2017

Time to Get Real About Real-World Evidence, Biopharma Execs Say

Pharmaceutical companies should not wait for the Food and Drug Administration (FDA) to specify how to use health data beyond traditional clinical trials for drug development, according to industry leaders.

Related Stories